The antimitotic activity of polyanions: heparin and heparinoids.
D000812:Anhydrides / Q000627:therapeutic use; D000818:Animals; D000838:Anions; D000917:Antibody Formation / Q000187:drug effects; D001713:Biphenyl Compounds / Q000494:pharmacology; D001777:Blood Coagulation / Q000187:drug effects; D004396:Coloring Agents / Q000627:therapeutic use; D004789:Enzyme Activation / Q000187:drug effects; D005030:Ethylenes / Q000627:therapeutic use; D006493:Heparin / Q000494:pharmacology* / Q000627:therapeutic use; D006496:Heparinoids / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D066298:In Vitro Techniques; D007369:Interferon Inducers / Q000494:pharmacology; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy; D008938:Mitosis / Q000187:drug effects*; D008970:Molecular Weight; D009368:Neoplasm Transplantation; D009369:Neoplasms / Q000188:drug therapy / Q000276:immunology; D010756:Phosphoric Acids / Q000494:pharmacology; D011070:Poly I-C / Q000627:therapeutic use; D011095:Polyethylenes / Q000627:therapeutic use; D011108:Polymers / Q000627:therapeutic use; D011119:Polynucleotides / Q000494:pharmacology; D011134:Polysaccharides / Q000627:therapeutic use; D011714:Pyrans / Q000627:therapeutic use
D000812:Anhydrides; D000838:Anions; D001713:Biphenyl Compounds; D004396:Coloring Agents; D005030:Ethylenes; D006496:Heparinoids; D007369:Interferon Inducers; D010756:Phosphoric Acids; D011095:Polyethylenes; D011108:Polymers; D011119:Polynucleotides; D011134:Polysaccharides; D011714:Pyrans; D006493:Heparin; D011070:Poly I-C